Colin E. Goldsmith
Impact in
-
- Nosocomial Infections in ICU
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 25
- Mycobacterium research and diagnosis 10
- Pneumonia and Respiratory Infections 7
-
- Antimicrobial Resistance in Staphylococcus 8
- Antifungal resistance and susceptibility 8
- Co-authors
- John E. Moore (70 shared papers)B. Cherie Millar (34 shared papers)Paul J. Rooney (24 shared papers)Anne Loughrey (23 shared papers)J.S. Elborn (24 shared papers)Yuriko Nagano (11 shared papers)Yasunori Maeda (13 shared papers)Shelley Gorman (2 shared papers)
- Journals
- Journal of Cystic Fibrosis (4 papers)Journal of Medical Microbiology (3 papers)British Journal of Biomedical Science (22 papers)Complementary Therapies in Clinical Practice (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United KingdomIrelandJapan
In The Last Decade
Colin E. Goldsmith
78 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 138
- Critical Care and Intensive Care Medicine 198
- Molecular Medicine 132
- Infectious Diseases 315
- Endocrinology 75
- Applied Microbiology and Biotechnology 25
Countries citing papers authored by Colin E. Goldsmith
This map shows the geographic impact of Colin E. Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin E. Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin E. Goldsmith more than expected).
Fields of papers citing papers by Colin E. Goldsmith
This network shows the impact of papers produced by Colin E. Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin E. Goldsmith. The network helps show where Colin E. Goldsmith may publish in the future.
Co-authors
The 25 scholars most cited alongside Colin E. Goldsmith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 283 | |
| 2 | 2008 | 108 | |
| 3 | 2010 | 70 | |
| 4 | 2010 | 58 | |
| 5 | 2008 | 55 | |
| 6 | 2007 | 47 | |
| 7 | 2010 | 47 | |
| 8 | 2007 | 46 | |
| 9 | 2007 | 42 | |
| 10 | 2007 | 41 | |
| 11 | 1999 | 36 | |
| 12 | An examination of antibacterial and antifungal properties of constituents described in traditional Ulster cures and remedies. | 2009 | 33 |
| 13 | 1997 | 32 | |
| 14 | 2008 | 32 | |
| 15 | 1993 | 30 | |
| 16 | 2009 | 27 | |
| 17 | 2009 | 26 | |
| 18 | 2008 | 23 | |
| 19 | 2010 | 23 | |
| 20 | Employment of broad range 16S rDNA PCR and sequencing in the detection of aetiological agents of meningitis. | 2005 | 22 |
About Colin E. Goldsmith
Colin E. Goldsmith is a scholar working on Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Biology and Clinical Biochemistry, having authored 81 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (13 papers), Mycobacterium research and diagnosis (10 papers), Antibiotic Resistance in Bacteria (8 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antifungal resistance and susceptibility (8 papers), Pneumonia and Respiratory Infections (7 papers) and Pharmaceutical and Antibiotic Environmental Impacts (6 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (198 citations), Molecular Medicine (132 citations), Infectious Diseases (315 citations), Endocrinology (75 citations) and Applied Microbiology and Biotechnology (25 citations). Colin E. Goldsmith has collaborated with scholars based in United Kingdom, Ireland and Japan. Frequent co-authors include John E. Moore, B. Cherie Millar, Paul J. Rooney, Anne Loughrey, J.S. Elborn, Yuriko Nagano, Yasunori Maeda, Shelley Gorman, Jackie Rendall and C. G. Adair. Their work appears in journals such as Journal of Cystic Fibrosis, Journal of Medical Microbiology, British Journal of Biomedical Science, Complementary Therapies in Clinical Practice and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.